David Lovejoy

Scientific Founder at Protagenic Therapeutics

A founder of the company from the beginning in September 2004, Dr. Lovejoy holds a Ph.D. in Neuroendocrinology from the University of Victoria (Victoria, BC) and spent three years at the Clayton Foundation Laboratories for Peptide Biology at the Salk Institute (San Diego, CA) as a postdoctoral fellow. Dr. Lovejoy took his first academic appointment at the University of Manchester (Manchester, UK), one of the United Kingdom’s top-ranking research universities. He joined the University of Toronto (Toronto, Ontario) in 2000 and is currently a Professor of Neuroendocrinology in the Department of Cell and Systems Biology at the University of Toronto. He is the author of more than 210 scientific publications including 3 books in the field and an Associate Editor for a scientific journal and is an inventor or co-inventor on all of the intellectual property.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Protagenic Therapeutics

Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders.


Employees

1-10

Links